Korean researchers found substance inhibiting COVID-19

„Korean researchers found substance inhibiting COVID-19“
„By Shim Hyun-tai
Published 2020.03.17 18:08
Updated 2020.03.20 18:12
A recent study is drawing the attention of the medical community, claiming that sea buckthorn berry’s lactic acid
bacteria can contain the spread of the new coronavirus by inhibiting the activation of its energy source, purine.
According to a research team at Ehwa Womans University Medical Center, it has confirmed probiotic bacteria
extracted from fermented sea buckthorn berry had lots of lactobacillus gasseri (L. gasseri), which represses the
activation of purine, an energy source required for the mutation of new coronavirus.
Professor Yoon Ha-na of the Department of Urology at Ehwa Womans University Medical Center
The group of researchers found L. gasseri while conducting experiments related to the inhibition of cytokine activity, and escherichia coli that inflame the bladder. The researchers, led by Professor Yoon Ha-na of the Urology Department, also discovered that sea buckthorn berry
had abundant amounts of ehstreptococcus thermophilus and lactobacillus rhamnosus, which have the same chemical
binding site to the COVID-19 and affect the protein activity of AIDS. They also confirmed nine antioxidants, six
minerals, and 16 amino acids.
In China, too, a research team led by Professor Ruan Jishou from Nankai University in Tianjin recently discovered
that COVID-19 in the human body mutated in a similar way to that of the Ebola and AIDS virus. According to the
Chinese research team, the new coronavirus creates spike protein to survive within the human body. The spike
protein contacts the cell membrane and attacks purine to acquire energy for its replication.
Korea is also using AIDS drugs to treat COVID-19 patients by inhibiting proteolytic enzyme activity. A patient’s
symptoms improved significantly in a few days after administrating Kaletra and AIDS drugs.
Professor Yoon expects the probiotic bacteria in sea buckthorn berry to be a supplementary treatment to suppress
COVID-19 spread by inhibiting purine activity.
“I believe the probiotic bacteria will work as a complementary treatment to prevent COVID-19 and will apply the same mechanism to additional studies, including cystitis and hyperlipidemia,” Professor Yoon said.
Professor Jeong Goo-bo of Gachon University Lee Gil Ya Cancer and Diabetes Institute, also said, “I believe L.
gasseri, derived from plants, can be effective in preventing COVID-19 spread because it affects the activation of
purine enzyme, the energy source for AIDS, hepatitis, Ebola, and COVID-19 virus.”
Korea Biomedical Review“
Source: http://www.koreabiomed.com/news/articleView.html